These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 28770390)

  • 1. Genome-wide significant, replicated and functional risk variants for Alzheimer's disease.
    Guo X; Qiu W; Garcia-Milian R; Lin X; Zhang Y; Cao Y; Tan Y; Wang Z; Shi J; Wang J; Liu D; Song L; Xu Y; Wang X; Liu N; Sun T; Zheng J; Luo J; Zhang H; Xu J; Kang L; Ma C; Wang K; Luo X
    J Neural Transm (Vienna); 2017 Nov; 124(11):1455-1471. PubMed ID: 28770390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.
    Han MR; Schellenberg GD; Wang LS;
    BMC Neurol; 2010 Oct; 10():90. PubMed ID: 20932310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Key Long Non-Coding RNAs in the Pathology of Alzheimer's Disease and their Functions Based on Genome-Wide Associations Study, Microarray, and RNA-seq Data.
    Han Z; Xue W; Tao L; Zhu F
    J Alzheimers Dis; 2019; 68(1):339-355. PubMed ID: 30776002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease.
    Coon KD; Myers AJ; Craig DW; Webster JA; Pearson JV; Lince DH; Zismann VL; Beach TG; Leung D; Bryden L; Halperin RF; Marlowe L; Kaleem M; Walker DG; Ravid R; Heward CB; Rogers J; Papassotiropoulos A; Reiman EM; Hardy J; Stephan DA
    J Clin Psychiatry; 2007 Apr; 68(4):613-8. PubMed ID: 17474819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancer variants associated with Alzheimer's disease affect gene expression via chromatin looping.
    Kikuchi M; Hara N; Hasegawa M; Miyashita A; Kuwano R; Ikeuchi T; Nakaya A
    BMC Med Genomics; 2019 Sep; 12(1):128. PubMed ID: 31500627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptome-wide piRNA profiling in human brains of Alzheimer's disease.
    Qiu W; Guo X; Lin X; Yang Q; Zhang W; Zhang Y; Zuo L; Zhu Y; Li CR; Ma C; Luo X
    Neurobiol Aging; 2017 Sep; 57():170-177. PubMed ID: 28654860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease.
    Broce IJ; Tan CH; Fan CC; Jansen I; Savage JE; Witoelar A; Wen N; Hess CP; Dillon WP; Glastonbury CM; Glymour M; Yokoyama JS; Elahi FM; Rabinovici GD; Miller BL; Mormino EC; Sperling RA; Bennett DA; McEvoy LK; Brewer JB; Feldman HH; Hyman BT; Pericak-Vance M; Haines JL; Farrer LA; Mayeux R; Schellenberg GD; Yaffe K; Sugrue LP; Dale AM; Posthuma D; Andreassen OA; Karch CM; Desikan RS
    Acta Neuropathol; 2019 Feb; 137(2):209-226. PubMed ID: 30413934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.
    Herold C; Hooli BV; Mullin K; Liu T; Roehr JT; Mattheisen M; Parrado AR; Bertram L; Lange C; Tanzi RE
    Mol Psychiatry; 2016 Nov; 21(11):1608-1612. PubMed ID: 26830138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide association analysis of age-at-onset in Alzheimer's disease.
    Kamboh MI; Barmada MM; Demirci FY; Minster RL; Carrasquillo MM; Pankratz VS; Younkin SG; Saykin AJ; ; Sweet RA; Feingold E; DeKosky ST; Lopez OL
    Mol Psychiatry; 2012 Dec; 17(12):1340-6. PubMed ID: 22005931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide analysis of genetic predisposition to Alzheimer's disease and related sex disparities.
    Nazarian A; Yashin AI; Kulminski AM
    Alzheimers Res Ther; 2019 Jan; 11(1):5. PubMed ID: 30636644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
    Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
    Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic risk for Alzheimer's disease is concentrated in specific macrophage and microglial transcriptional networks.
    Tansey KE; Cameron D; Hill MJ
    Genome Med; 2018 Feb; 10(1):14. PubMed ID: 29482603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF-A-related genetic variants protect against Alzheimer's disease.
    Petrelis AM; Stathopoulou MG; Kafyra M; Murray H; Masson C; Lamont J; Fitzgerald P; Dedoussis G; Yen FT; Visvikis-Siest S
    Aging (Albany NY); 2022 Mar; 14(6):2524-2536. PubMed ID: 35347084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Data integration for functional annotation of regulatory single nucleotide polymorphisms associated with Alzheimer's disease susceptibility.
    Amber S; Zahid S
    Gene; 2018 Sep; 672():115-125. PubMed ID: 29883757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manifestations of Alzheimer's disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90.
    Heath L; Earls JC; Magis AT; Kornilov SA; Lovejoy JC; Funk CC; Rappaport N; Logsdon BA; Mangravite LM; Kunkle BW; Martin ER; Naj AC; Ertekin-Taner N; Golde TE; Hood L; Price ND;
    Sci Rep; 2022 Apr; 12(1):6117. PubMed ID: 35413975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shared genetic etiology underlying Alzheimer's disease and type 2 diabetes.
    Hao K; Di Narzo AF; Ho L; Luo W; Li S; Chen R; Li T; Dubner L; Pasinetti GM
    Mol Aspects Med; 2015; 43-44():66-76. PubMed ID: 26116273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convergent lines of evidence support BIN1 as a risk gene of Alzheimer's disease.
    Zhu J; Liu X; Yin H; Gao Y; Yu H
    Hum Genomics; 2021 Jan; 15(1):9. PubMed ID: 33516273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep post-GWAS analysis identifies potential risk genes and risk variants for Alzheimer's disease, providing new insights into its disease mechanisms.
    Wang Z; Zhang Q; Lin JR; Jabalameli MR; Mitra J; Nguyen N; Zhang ZD
    Sci Rep; 2021 Oct; 11(1):20511. PubMed ID: 34654853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation at the CELF1 (CUGBP, elav-like family member 1 gene) locus is genome-wide associated with Alzheimer's disease and obesity.
    Hinney A; Albayrak O; Antel J; Volckmar AL; Sims R; Chapman J; Harold D; Gerrish A; Heid IM; Winkler TW; Scherag A; Wiltfang J; Williams J; Hebebrand J; ; ;
    Am J Med Genet B Neuropsychiatr Genet; 2014 Jun; 165B(4):283-93. PubMed ID: 24788522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning.
    Neumann A; Ohlei O; Küçükali F; Bos IJ; Timsina J; Vos S; Prokopenko D; Tijms BM; Andreasson U; Blennow K; Vandenberghe R; Scheltens P; Teunissen CE; Engelborghs S; Frisoni GB; Blin O; Richardson JC; Bordet R; Lleó A; Alcolea D; Popp J; Marsh TW; Gorijala P; Clark C; Peyratout G; Martinez-Lage P; Tainta M; Dobson RJB; Legido-Quigley C; Van Broeckhoven C; Tanzi RE; Ten Kate M; Lill CM; Barkhof F; Cruchaga C; Lovestone S; Streffer J; Zetterberg H; Visser PJ; Sleegers K; Bertram L;
    Genome Med; 2023 Oct; 15(1):79. PubMed ID: 37794492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.